RT Journal Article
T1 Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.
A1 Ramos-Martinez, Antonio
A1 Parra-Ramirez, Lina Marcela
A1 Morras, Ignacio
A1 Carnevali, María
A1 Jimenez-Ibañez, Lorena
A1 Rubio-Rivas, Manuel
A1 Arnalich, Francisco
A1 Beato, Jose Luis
A1 Monge, Daniel
A1 Asin, Uxua
A1 Suarez, Carmen
A1 Freire, Santiago Jesus
A1 Mendez-Bailon, Manuel
A1 Perales, Isabel
A1 Loureiro-Amigo, Jose
A1 Gomez-Belda, Ana Belen
A1 Pesqueira, Paula Maria
A1 Gomez-Huelgas, Ricardo
A1 Mella, Carmen
A1 Diez-García, Luis Felipe
A1 Fernandez-Sola, Joaquim
A1 Gonzalez-Ferrer, Ruth
A1 Aroza, Marina
A1 Anton-Santos, Juan Miguel
A1 Lumbreras-Bermejo, Carlos
K1 Glucocorticoids
K1 Hemoglobins
K1 Bacterial Infections
K1 Heart Failure
K1 COVID‑19
AB To determine the proportion of patients with COVID-19 who were readmitted to the hospital and the most common causes and the factors associated with readmission. Multicenter nationwide cohort study in Spain. Patients included in the study were admitted to 147 hospitals from March 1 to April 30, 2020. Readmission was defined as a new hospital admission during the 30 days after discharge. Emergency department visits after discharge were not considered readmission. During the study period 8392 patients were admitted to hospitals participating in the SEMI-COVID-19 network. 298 patients (4.2%) out of 7137 patients were readmitted after being discharged. 1541 (17.7%) died during the index admission and 35 died during hospital readmission (11.7%, p = 0.007). The median time from discharge to readmission was 7 days (IQR 3-15 days). The most frequent causes of hospital readmission were worsening of previous pneumonia (54%), bacterial infection (13%), venous thromboembolism (5%), and heart failure (5%). Age [odds ratio (OR): 1.02; 95% confident interval (95% CI): 1.01-1.03], age-adjusted Charlson comorbidity index score (OR: 1.13; 95% CI: 1.06-1.21), chronic obstructive pulmonary disease (OR: 1.84; 95% CI: 1.26-2.69), asthma (OR: 1.52; 95% CI: 1.04-2.22), hemoglobin level at admission (OR: 0.92; 95% CI: 0.86-0.99), ground-glass opacification at admission (OR: 0.86; 95% CI:0.76-0.98) and glucocorticoid treatment (OR: 1.29; 95% CI: 1.00-1.66) were independently associated with hospital readmission. The rate of readmission after hospital discharge for COVID-19 was low. Advanced age and comorbidity were associated with increased risk of readmission.
PB Nature Publishing Group
YR 2021
FD 2021-07-02
LK http://hdl.handle.net/10668/18150
UL http://hdl.handle.net/10668/18150
LA en
NO Ramos-Martínez A, Parra-Ramírez LM, Morrás I, Carnevali M, Jiménez-Ibañez L, Rubio-Rivas M, et al. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients. Sci Rep. 2021 Jul 2;11(1):13733
DS RISalud
RD Apr 6, 2025